ArticleJCO precision oncology2024

Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring

Alessandro Di Federico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.